Empirical Financial Services LLC d.b.a. Empirical Wealth Management Boosts Holdings in Eli Lilly and Company $LLY

Empirical Financial Services LLC d.b.a. Empirical Wealth Management expanded its investment in Eli Lilly and Company (NYSE:LLY) by 6.9% in the second quarter, accumulating an additional 887 shares. By quarter’s end, the fund owned a total of 13,747 shares, reflecting continued confidence in the pharmaceutical leader.

Key Takeaways:

  • Empirical boosted its stake in Eli Lilly by 6.9% in Q2
  • An additional 887 shares were acquired, raising the total to 13,747
  • HoldingsChannel provided the data for this investment shift
  • The expansion suggests a positive outlook on Eli Lilly’s performance
  • The Lincolnian Online first published these findings

Empirical’s Second-Quarter Drive

Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its investment in Eli Lilly and Company, one of the world’s foremost pharmaceutical firms, by 6.9% during the second quarter. This move underscores the firm’s commitment to the drugmaker amid a competitive and evolving healthcare market.

Additional Shares Acquired

According to HoldingsChannel, the fund added 887 Eli Lilly shares during the quarter. As a result, Empirical Wealth Management’s stake increased to a total of 13,747 shares. The boost highlights the fund’s ongoing confidence in Eli Lilly’s growth potential and market position.

Why the 6.9% Increase Matters

A 6.9% uptick in holdings can be more than just a small maneuver. It points to the fund’s strategic interest in a stock that has consistently attracted investors looking for strong returns in the pharmaceutical sector. This expansion might reflect positive sentiment based on Eli Lilly’s performance and pipeline developments.

Looking Ahead

Though the company’s future performance was not discussed in the original content, Empirical’s decision to heighten its stake speaks volumes about its current outlook. With 13,747 shares now under management, the firm’s actions signal a measured endorsement of Eli Lilly’s track record and prospects.

Source and Timing

This information, reported by HoldingsChannel and published by The Lincolnian Online on October 3, 2025, underscores the transparent nature of financial updates for publicly traded entities. Investors who track these shifts often watch for changes that might signal broader trends or confidence in a company’s fundamentals.

More from World

Grants Shift to Boost Workforce Skills
by Mychesco
19 hours ago
2 mins read
Education, Labor Redirect Grants Toward Workforce Training
Trump’s Explosive Call to Arab Leaders
by Express
19 hours ago
1 min read
Trump stuns Arab leaders in leaked phone call as he vows to ‘blow s*** up’
What Is A Realistic Ceiling, Floor And Baseline For Virginia Tech’s 2026 Season?
Hokies vs. Cal Poly: NCAA Tournament Showdown
by Roanoke
22 hours ago
2 mins read
Virginia Tech baseball gets NCAA bid, heading to Los Angeles
Central Texas Softball Falls in State Semis
by Austin American-statesman
22 hours ago
1 min read
All four remaining Central Texas softball teams get bounced in UIL state semifinals
Green Bay's Bold Defensive Move Looms
by Yardbarker
1 day ago
1 min read
Packers still appear positioned for bold offseason move and proposed addition could realistically happen
Should Bend Limit Public Voices in Governance?
by The Bulletin
1 day ago
1 min read
Editorial: Would Bend be better with less public involvement?
Detroit Tigers infielder Max Anderson takes batting practice.
Coolidge: Yuba-Sutter's Voice for Assembly
by Appeal Democrat
1 day ago
1 min read
Letter to the Editor: Don’t overlook Coolidge
United by Outrage: Data Centers in Crosshairs
by Rolling Stone
1 day ago
2 mins read
Can Local Outrage Over Data Centers Tilt the Midterms?
Why $150 Oil Eludes Expectations
by Oil Price
1 day ago
2 mins read
Why Hasn’t Oil Hit $150?
Deepfake Porn Arrests Reveal AI's Dark Side
by Futurism
1 day ago
2 mins read
Two Men Arrested for Creating AI Deepfake Porn